Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

Cited by (480)

Items 301–400 of 480

1. Introduction to Clinical Pharmacology
   Rommel G. Tirona, Richard B. Kim · 2009 · Elsevier eBooks
2. Drug Excretion
   David R. Taft · 2009 · Elsevier eBooks
3. Dermal Blood Flow, Lymphatics, and Binding as Determinants of Topical Absorption, Clearance, and Distribution
   S. E. Cross, Michael Stephen Roberts · 2005 · CRC Press eBooks
4. Kirchhoff’s Laws and Hepatic Clearance, Well-Stirred Model – Is There Common Ground?
   M. Rowland, M. Weiss, K. Pang · 2023 · Drug Metabolism And Disposition
5. Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance
   Xiao-Nan Li, W. Jusko · 2023 · Drug Metabolism And Disposition
6. A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter f d in Physiologically Based Pharmacokinetics
   Yoo‐Seong Jeong, William J. Jusko · 2023 · Journal of Pharmaceutical Sciences
7. Discovery of the first potent and selective αvβ5 integrin inhibitor based on an amide-containing core
   Rhys A. Lippa, John Barrett, Sandeep Pal, James E. Rowedder, John Anthony Murphy, Tim N. Barrett · 2020 · European Journal of Medicinal Chemistry
8. Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug Ratio
   R. Obach, Jian Lin, E. Kimoto, S. Duvvuri, T. Nicholas, Eugene P. Kadar, L. Tremaine, A. Sawant-Basak · 2018 · Drug Metabolism And Disposition
9. Online monitoring of hepatic rat metabolism by coupling a liver biochip and a mass spectrometer.
   F. Merlier, R. Jellali, E. Leclerc · 2017 · In Analysis
10. Characterization of fimasartan metabolites in human liver microsomes and human plasma
    Ji-Yoon Lee, Young Jae Choi, S. Oh, Y. Chi, S. Paik, Kiho Lee, Jae-Kyung Jung, C. Ryu, K. Kim, Dong-Hyun Kim et al. · 2016 · Xenobiotica; the fate of foreign compounds in biological systems
11. The identification of lobeglitazone metabolites in rat liver microsomes and the kinetics of the in vivo formation of the major metabolite M1 in rats.
    Jong-Hwa Lee, Sung-Hoon Ahn, H. Maeng, Wooin Lee, Dae-Duk Kim, S. Chung · 2015 · Journal of Pharmaceutical and Biomedical Analysis
12. SELECTIVE EFFECTS OF NITRIC OXIDE ON THE DISPOSITION OF CHLORZOXAZONE AND DEXTROMETHORPHAN IN ISOLATED PERFUSED RAT LIVERS
    R. Vuppugalla, R. Mehvar · 2006 · Drug Metabolism And Disposition
13. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    L. Berezhkovskiy · 2006 · Journal of Pharmacy and Science
14. On the Degree of Solute Mixing in Liver Models of Drug Elimination
    M. Weiss · 1997 · Journal of pharmacokinetics and biopharmaceutics
15. Concentration-dependent metabolism of diazepam in mouse liver
    M. st-Pierre, K. Pang · 1995 · Journal of pharmacokinetics and biopharmaceutics
16. In Vitro Models for Plasma Binding and Tissue Storage
    Patrick Barton, Rupert P. Austin, Roger E. Fessey · 2007 · Elsevier eBooks
17. Analysis methods and recent advances in nonlinear pharmacokinetics from in vitro through in loci to in vivo.
    K. Yamaoka, Y. Takakura · 2004 · Drug Metabolism and Pharmacokinetics
18. Microsomal Cytochrome P450 Levels and Activities of Isolated Rat Livers Perfused with Albumin
    Ragini Vuppugalla, Rakhi B. Shah, Anjaneya Chimalakonda, Charles Fisher, Reza Mehvar · 2003 · Pharmaceutical Research
19. ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application
    He-Qun Li, Fazila Bunglawala, N. Hewitt, R. Pendlington, R. Cubberley, B. Nicol, S. Spriggs, M. Baltazar, S. Cable, M. Dent · 2023 · Toxicological Sciences
20. In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
    Hyun-Jae Cho, Young Jun Kim, J. Chae, Markus R. Meyer, S. K. Kim, C. Ryu · 2023 · Frontiers in Pharmacology
21. In vitro–in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to human
    Mo’tasem M. Alsmadi, Saja B. Alzughoul · 2022 · Biopharmaceutics & Drug Disposition
22. A novel galactose electrochemical biosensor intended for point-of-care measurement of quantitative liver function using galactose single-point test
    Kuo-ming Yu, Ping Yang, Tien-Yu Huang, T. Shen, J. Lau, O. Hu · 2022 · Analytical and Bioanalytical Chemistry
23. Pharmacokinetic Profile of Doxycycline in Koala Plasma after Weekly Subcutaneous Injections for the Treatment of Chlamydiosis
    Chien-Jung Chen, Amber K. Gillett, R. Booth, B. Kimble, M. Govendir · 2022 · Animals
24. Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailability
    Neha Maharao, J. Venitz, P. Gerk · 2019 · Biopharmaceutics & drug disposition
25. PBPK Modeling to Unravel Nonlinear Pharmacokinetics of Verapamil to Estimate the Fractional Clearance for Verapamil N-Demethylation in the Recirculating Rat Liver Preparation
    Q. Yang, Lu-Qin Si, Hui Tang, H. H. Sveigaard, E. Chow, K. Pang · 2015 · Drug Metabolism And Disposition
26. A comparative investigation of hepatic clearance models: Predictions of metabolite formation and elimination
    Marie V. St–Pierre, Ping I. Lee, K. Sandy Pang · 1992 · Journal of Pharmacokinetics and Biopharmaceutics
27. A nonlinear physiologic pharmacokinetic model: I. Steady-state
    John G. Wagner, Gregory J. Szpunar, James J. Ferry · 1985 · Journal of Pharmacokinetics and Biopharmaceutics
28. Complex Drug Interactions: Significance and Evaluation
    Ping Zhao, Lei Zhang, Shiew Mei Huang · 2009 · Springer eBooks
29. Predicting Human Oral Bioavailability Using in Silico Models
    Lawrence X. Yu, Christopher D. Ellison, Ajaz S Hussain · 2004 · Springer eBooks
30. Pharmacokinetics of tafamidis, a transthyretin amyloidosis drug, in rats
    Kyeong-Ryoon Lee, Jong-Woo Jeong, Hun-Chan Hyun, Eunseo Jang, Sunjoo Ahn, Sungwook Choi, S. Joo, Sungsub Kim, Tae-Sung Koo · 2018 · Xenobiotica; the fate of foreign compounds in biological systems
31. An integer programming approach for optimal drug dose computation
    P. Sopasakis, H. Sarimveis · 2012 · Comput. Methods Programs Biomed.
32. New method for the simultaneous estimation of intrinsic hepatic clearance and protein binding by matrix inhibition
    Takahide Uchimura, Motohiro Kato, Tatsuhiko Tachibana, S. Arai, Y. Nabuchi, Kimitoshi Saito, H. Kinoshita · 2008 · Biopharmaceutics & drug disposition
33. Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs
    Laurent P. Rivory, Michael Stephen Roberts, Susan M. Pond · 1992 · Journal of Pharmacokinetics and Biopharmaceutics
34. Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope
    M. Guerret, G. Cheymol, M. Hubert, C. Julien-Larose, D. Lavene · 2004 · European Journal of Clinical Pharmacology
35. Plasma Protein Binding as an Optimizable Parameter for In Vivo Efficacy
    Hong-Tao Zhao · 2025 · bioRxiv
36. Mechanisms of altered hepatic drug disposition during pregnancy: small molecules
    Muluneh M. Fashe, Jacqueline B. Tiley, Craig R. Lee · 2025 · Expert Opinion on Drug Metabolism & Toxicology
37. Notes on the Use of Kirchhoff’s Laws in Pharmacokinetics
    Ronald A. Siegel · 2023 · AAPS Journal
38. Combined translational pharmacometrics approach to support the design and conduct of the first‐in‐human study of DWP16001
    So Jin Lee, Soo Hyeon Bae, Sangil Jeon, Hye Young Ji, Seunghoon Han · 2023 · British Journal of Clinical Pharmacology
39. Characterisation of intravenous pharmacokinetics in Göttingen minipig and clearance prediction using established in vitro to in vivo extrapolation methodologies
    Kristine Langthaler, Christopher R. Jones, Rasmus B. Christensen, Elin Eneberg, Birger Brodin, Christoffer Bundgaard · 2022 · Xenobiotica
40. Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling.
    S. Kweon, Yoo-Seong Jeong, Seung-Woo Chung, Hanul Lee, Ha-Kyeong Lee, S. Park, J. U. Choi, Jooho Park, S. Chung, Y. Byun · 2022 · Biomaterials
41. Effects of age and gender on the cytochrome P450 2D6 activity in a Korean population
    P. Park, Y. Seo, J. Ahn, Kyoung-Ah Kim, Ji-Young Park · 2021 · Journal of Clinical Pharmacy and Therapeutics
42. Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients
    M. Chirehwa, R. Court, M. de Kock, L. Wiesner, N. de Vries, J. Harding, T. Gumbo, G. Maartens, R. Warren, P. Denti et al. · 2021 · Antimicrobial Agents and Chemotherapy
43. Evaluation of a Competitive Equilibrium Dialysis Approach for Assessing the Impact of Protein Binding on Clearance Predictions
    Robert S. Jones, Jae H. Chang, M. Flores, E. Brecht · 2020 · Journal of Pharmacy and Science
44. Spatially antiviral dynamics determines HCV in vivo replication and evolution.
    Chen-Tong Li, Ying-Ying Zhang, Yi-Cang Zhou · 2020 · Journal of Theoretical Biology
45. Further Assessment of the Relay Hepatocyte Assay for Determination of Intrinsic Clearance of Slowly Metabolised Compounds Using Radioactivity Monitoring and LC–MS Methods
    R. Murgasova · 2019 · European journal of drug metabolism and pharmacokinetics
46. Theoretical consideration of the properties of intestinal flow models on route‐dependent drug removal: Segregated Flow (SFM) vs. Traditional (TM)
    Keumhan Noh, K. Sandy Pang · 2019 · Biopharmaceutics & Drug Disposition
47. Pradigastat disposition in humans:in vivoandin vitroinvestigations
    Alana L. Upthagrove, Jin Chen, Charles Daniel Meyers, Kenneth M. Kulmatycki, Angela Bretz, Lai Wang, Lana Peng, Safet Palamar, Melissa Lin, Tapan Majumdar et al. · 2016 · Xenobiotica
48. Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first-pass removal with PBPK modeling.
    K. Pang, Q. Yang, K. Noh · 2017 · Biopharmaceutics & drug disposition
49. Mechanistic investigations into the species differences in pinometostat clearance: impact of binding to alpha-1-acid glycoprotein and permeability-limited hepatic uptake
    Sherri A. Smith, Sandra Gagnon, Nigel J. Waters · 2016 · Xenobiotica
50. Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.
    L. Berezhkovskiy · 2009 · Journal of Pharmacy and Science
51. Prediction of metabolic clearance of diclofenac in adjuvant-induced arthritis rats using a substrate depletion assay
    S. Uno, A. Fujii, H. Komura, A. Kawase, M. Iwaki · 2008
52. Theoretical consideration of drug distribution kinetics in a noneliminating organ: Comparison between a “homogeneous (well-stirred)” model and “nonhomogeneous (tube)” model
    T. Terasaki, Y. Sugiyama, T. Iga, Y. Sawada, M. Hanano · 1985 · Journal of pharmacokinetics and biopharmaceutics
53. Impact of Physiological Determinants: Flow, Binding, Transporters and Enzymes on Organ and Total Body Clearances
    K. Sandy Pang, Huadong Sun, Edwin C.Y. Chow · 2009 · Springer eBooks
54. Population pharmacokinetics of pyrazinamide and isoniazid in plasma and cerebrospinal fluid from South African adults with tuberculous meningitis
    José Miguel Calderín Miranda, Sean A Wasserman, Juan Eduardo Reséndiz‐Galván, Noha Abdelgawad, Angharad Davis, Cari J. Stek, Lubbe Wiesner, Robert John Wilkinson, Paolo Denti · 2025 · Antimicrobial Agents and Chemotherapy
55. Hepatic and extra-hepatic metabolism of propylene glycol ethers in the context of central nervous system toxicity
    Sophie Werner, David Pamies, Marie‐Gabrielle Zurich, Laura Suter‐Dick · 2025 · Toxicology
56. Quantitative pulmonary pharmacokinetics of tetrandrine for SARS-CoV-2 repurposing: a physiologically based pharmacokinetic modeling approach
    Fu-zhe Wang, Liuhan Dong, Juanwen Hu, Shi-Jie Yang, Ling-juan Wang, Zhi-Wei Zhang, Wenpeng Zhang, Xiaomei Zhuang · 2024 · Frontiers in Pharmacology
57. The history and future of population pharmacokinetic analysis in drug development
    Nathan S. Teuscher · 2023 · Xenobiotica
58. Evidence of the Need for Modified Well-stirred Model in In Vitro to In Vivo Extrapolation.
    Tien-Yu Chang, Hong-Jaan Wang, Shu-Hao Hsu, M. Chang, L. Kao, Li-Heng Pao · 2022 · European Journal of Pharmaceutical Sciences
59. Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity
    R. Thelingwani, Britta Bonn, K. Chibale, C. Masimirembwa · 2014 · Expert Opinion on Drug Metabolism & Toxicology
60. Metabolism and clinical pharmacokinetics of 2-methyl-n-(2′-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1′-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration ofin vitroADME tools
    Aarti Sawant Basak, Wonkyung Byon, Elaine Tseng-Lovering, Carrie Funk, Linda S. Wood, Chang Lin, Marielle Delnomdedieu, Patrick R. Verhoest, Vinod D. Parikh, Loretta M. Cox et al. · 2013 · Xenobiotica
61. Metabolite Mean Transit Times in the Liver as Predicted By Various Models of Hepatic Elimination
    George D. Mellick, Yuri G. Anissimov, Anthony J. Bracken, Michael Stephen Roberts · 1997 · Journal of Pharmacokinetics and Biopharmaceutics
62. Generalized pharmacokinetic modeling for drugs with nonlinear binding: I. Theoretical framework
    W. Gillespie · 1993 · Journal of pharmacokinetics and biopharmaceutics
63. Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction
    Robert H. M. Smallwood, G. Mihaly, R. Smallwood, D. Morgan · 1988 · Journal of pharmacokinetics and biopharmaceutics
64. Lack of linear correlation between hepatic ligand uptake rate and unbound ligand concentration does not necessarily imply receptor-mediated uptake
    Robert H. M. Smallwood, D. Morgan, G. Mihaly, R. Smallwood · 1988 · Journal of pharmacokinetics and biopharmaceutics
65. The assessment of bioavailability in the presence of nonlinear elimination
    S. Hall, C. McAllister, G. Wilkinson · 1988 · Journal of pharmacokinetics and biopharmaceutics
66. Effect of plasma protein binding on drug disposition in muscle tissue: Application of statistical moment analysis and network theory toin situ local single-pass perfusion system
    T. Kakutani, E. Sumimoto, M. Hashida · 1988 · Journal of pharmacokinetics and biopharmaceutics
67. Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in “enzyme-distributed” models: A computer-aided simulation study
    S. Miyauchi, Y. Sugiyama, Hitoshi Sato, Y. Sawada, T. Iga, M. Hanano · 1987 · Journal of pharmacokinetics and biopharmaceutics
68. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog
    S. Bai, U. Walle, T. Walle · 1985 · Journal of pharmacokinetics and biopharmaceutics
69. Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: Cases of nonportal route of administration
    E. Lane, R. Levy · 1981 · Journal of pharmacokinetics and biopharmaceutics
70. Distribution – in vitro Tests – Protein Binding
    J. Riedel · 2006
71. Intravenous Pharmacokinetics and Metabolism of the Reactive Oxygen Scavenger α-Phenyl-N-Tert-Butyl Nitrone (PBN) in the Cynomolgus Monkey
    M. Lame, Amit S. Kalgutkar, Michael Lafontaine · 2004 · Drug Metabolism and Drug Interactions
72. Population Pharmacokinetics of Tideglusib in Congenital and Childhood Myotonic Dystrophy Type 1: Influence of Demographic and Clinical Factors on Systemic Exposure
    A. Di Deo, S. Oosterholt, Joseph P. Horrigan, Stuart Evans, A. McMorn, O. Della Pasqua · 2025 · Pharmaceutics
73. Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance
    Julia A. Schulz Pauly, Jin Wang, Colin J. Phipps, J. Kalvass · 2023 · Drug Metabolism And Disposition
74. Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
    Stijn W. van Beek, E. Svensson, A. Tiono, J. Okebe, U. D'Alessandro, B. Gonçalves, T. Bousema, C. Drakeley, R. ter Heine · 2021 · Parasites & Vectors
75. Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteers
    Michael Derks, Sian Lennon-Chrimes, Andreas Guenther, Lisa Squassante, Christoph Wandel, Piotr J. Szczesny, Axel Paehler, Heidemarie Kletzl · 2021 · Expert Opinion on Investigational Drugs
76. In vitro and in vivo evaluation of hypothermia on pharmacokinetics and pharmacodynamics of nimodipine in rabbits
    Y. Fei, Tian-hong Zhang, Jing Zhao, H. Ren, Yanni Du, Chun’e Yu, Qiang Wang, Shu Li, Ting-lin Ren, Q. Jian et al. · 2017 · Journal of International Medical Research
77. A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats
    Yu Jiang, Gary Milavetz, Margaret O. James, Guohua An · 2017 · Journal of Pharmaceutical Sciences
78. System approach to modeling of liver glucose metabolism with physiologically interpreted model parameters outgoing from [18F]FDG concentrations measured by PET
    Z. Rausová, J. Chrenova, P. Nuutila, P. Iozzo, L. Dedík · 2012 · Comput. Methods Programs Biomed.
79. Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model.
    Li-Chuan Liu, Huadong Sun, Wiqas Y. Valji, K. S. Pang · 2007 · American Journal of Physiology - Gastrointestinal and Liver Physiology
80. Prediction of Hepatic Clearance in Humans from Experimental Animals and In Vitro Data
    Masato Chiba, Yuichi Sugiyama, Yasuyuki Ishii, Hiroyuki Takahashi, Yoshihiro Shibata · 2003 · Informa Healthcare eBooks
81. An understanding of flow- and diffusion-limited vs. Carrier-mediated hepatic transport: A simulation study
    Wanping Geng, K. Poon, K. Pang · 1995 · Journal of pharmacokinetics and biopharmaceutics
82. The Effect of Valproate on the Metabolism of Phenobarbital in the Rat
    G. Anderson, R. Levy · 1992 · Pharmaceutical Research
83. Pharmacometrics: A Quantitative Decision-Making Tool in Drug Development
    Yan Chun Xu, Holly H. C. Kimko · 2020 · Springer eBooks
84. Thermal Injury Decreases Hepatic Blood Flow and the Intrinsic Clearance of Indocyanine Green in the Rat
    G. M. Pollack, K. Brouwer · 2004 · Pharmaceutical Research
85. Advancing Hepatic Clearance Prediction Across In Vitro, Ex Situ, and In Vivo Systems to Facilitate In Vitro-to-In Vivo Extrapolation.
    Hsin-Chung Cheng, Hsueh-Tien Chen, Hsin-Ying Chen, Nai-Hsin Chou, Hong-Jaan Wang, Li-Heng Pao, Sung-Ling Tang · 2025 · European Journal of Pharmaceutical Sciences
86. Using partition analysis as a facile method to derive net clearances
    K. Korzekwa, J. Yadav, S. Nagar · 2022 · Clinical and Translational Science
87. Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis
    L. E. van der Laan, A. Garcia-Prats, H. S. Schaaf, M. Chirehwa, J. Winckler, Jun Mao, H. Draper, L. Wiesner, J. Norman, H. McIlleron et al. · 2022 · Antimicrobial Agents and Chemotherapy
88. Pharmacokinetics: Drug absorption, distribution, metabolism, and excretion (ADME)
    R. Shah · 2019 · The Pharma Innovation
89. Establishing species-specific 3D liver microtissues for repeat dose toxicology and advancing in vitro to in vivo translation through computational modelling
    J. Kyffin · 2018
90. Integrated Assessment of Drug Clearance and Cross‐Species Scalability
    Kevin C. Beaumont, James R. Gosset, Christopher E. Keefer · 2014 · Wiley eBooks
91. Hepatic Biotransformation and Biliary Excretion
    R. Baynes, J. Riviere · 2011
92. Drug structure–transport relationships
    Michael Stephen Roberts · 2010 · Journal of Pharmacokinetics and Pharmacodynamics
93. A convenient method for estimating the quantity of drug eliminated by the routes other than hepatic metabolism and renal excretion and the fraction of drug that reaches the "first pass" after oral administration.
    L. Berezhkovskiy · 2006 · Journal of Pharmacy and Science
94. New hepatocellular diffusion model for analysis of hepatobiliary transport processes of drugs
    H. Yasui, K. Yamaoka, T. Nakagawa · 1995 · Journal of pharmacokinetics and biopharmaceutics
95. Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of Piroxicam in vivo in the rat
    J. I. F. Troconiz, L. G. Lopez-Bustamante, D. Fos · 1993 · European journal of drug metabolism and pharmacokinetics
96. Disposition of prednisone and prednisolone in the perfused rabbit liver: Modeling hepatic metabolic processes
    V. Hale, K. Aizawa, L. Sheiner, L. Benet · 1991 · Journal of pharmacokinetics and biopharmaceutics
97. Hepatic elimination of drugs with concentration-dependent serum protein binding
    Jin-Ding Huang, S. Oie · 1984 · Journal of pharmacokinetics and biopharmaceutics
98. Oral Drug Delivery, Absorption and Bioavailability
    David Dahlgren, Hans Lennernäs · 2021 · Elsevier eBooks
99. Prediction of Drug Clearance from Enzyme and Transporter Kinetics
    Priyanka Kulkarni, Amir S. Youssef, Aneesh A. Argikar · 2021 · Methods in molecular biology
100. Drug-Drug Interactions With a Pharmacokinetic Basis
     Lisa Cheng, T. Chang, H. Wong · 2021 · Reference Module in Biomedical Sciences